Signature Estate & Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-484
Closed -$116K 190
2017
Q1
$116K Sell
484
-42
-8% -$9.78K 0.01% 182
2016
Q4
$110K Sell
526
-444
-46% -$92K 0.02% 150
2016
Q3
$223K Sell
970
-638
-40% -$156K 0.03% 119
2016
Q2
$372K Sell
1,608
-42,591
-96% -$9.82M 0.06% 93
2016
Q1
$11.8M Buy
44,199
+2,058
+5% +$589K 1.94% 20
2015
Q4
$13.2M Buy
42,141
+4,742
+13% +$1.41M 2.27% 14
2015
Q3
$10.2M Buy
37,399
+3,475
+10% +$1.07M 2.12% 18
2015
Q2
$10.3M Buy
33,924
+7,464
+28% +$2.23M 2.3% 19
2015
Q1
$7.88M Buy
+26,460
New +$7.54M 2.08% 26

Other funds holding AGN

Signature Estate & Investment Advisors's AGN Position: Q2 2017 in Review

Signature Estate & Investment Advisors sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 484 shares — an estimated $116K sold.

Signature Estate & Investment Advisors first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $13.2M in Q4 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Signature Estate & Investment Advisors reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 484 Allergan plc shares in Q2 2017, an estimated $116K.
  • Signature Estate & Investment Advisors first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Signature Estate & Investment Advisors's Allergan plc position peaked at $13.2M in Q4 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.